Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomegranate Juice and IV Iron in Hemodialysis
NCT02107053Completed
- Sponsor
- Galilee Medical Center
- Start
- Apr 2014
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
Randomised, open-label trial in atherosclerosis and cardiovascular disease (CVD), sponsored by Galilee Medical Center. Primary endpoint: Oxidation Reduction Potential. Started Apr 2014; status: completed.
02
Conditions
atherosclerosiscardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02107053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107053.